Recent Updates
Recently added Catalysts
NGEN Positive Sentiment Score: 85/100

Form 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Reporting Issuer NervGen Pharma Corp. (" NervGen " or the " Company ") 112-970 Burrard Street Unit 1290 Vancouver, BC V6Z 2R4 Item 2. Date of Material Chan

Thursday, January 8, 2026 1 min read
Key Takeaway: NervGen Pharma Corp. has announced that its common shares have been approved for listing on the Nasdaq stock exchange, effective January 8, 2026. The company's shares will trade under the symbol 'NGEN'. This listing represents a pivotal achievement for NervGen, providing them with increased visibility and access to capital markets. The news was disseminated through GlobeNewswire and filed accordingly on SEDAR+.

Market Sentiment Analysis

POSITIVE FACTORS

  • NervGen Pharma's common shares have been approved for listing on Nasdaq.
  • Trading under the symbol 'NGEN' started on January 8, 2026.
  • The listing is a significant milestone for the company.

Full Press Release Details

MATERIAL CHANGE REPORT
NervGen Pharma Corp. ("NervGen" or the "Company")
112-970 Burrard Street
Vancouver, BC V6Z 2R4
A news release announcing the material
change was disseminated on January 8, 2026 through GlobeNewswire distribution network, and a copy was filed on NervGen's SEDAR+
profile at www.sedarplus.ca.
On January 8, 2026, the Company announced
the Company's common shares have been approved for listing on Nasdaq.
On January 8, 2026, the Company announced
the Company's common shares have been approved for listing on Nasdaq. NervGen's common shares began trading on Nasdaq as of January 8,
2026, under the symbol "NGEN."
No information has been omitted on the
basis that it is confidential information.
William Adams, Chief Financial
112-970 Burrard Street
Vancouver, BC V6Z 2R4

Frequently Asked Questions

What did NervGen Pharma announce on January 8, 2026?

NervGen Pharma announced that its common shares were approved for listing on Nasdaq.

Under what symbol are NervGen's shares trading on Nasdaq?

NervGen's shares are trading on Nasdaq under the symbol 'NGEN'.

Where can I find the material change report for NervGen?

The material change report is available on NervGen's SEDAR+ profile at www.sedarplus.ca.

Who is the Chief Financial Officer of NervGen?

William Adams serves as the Chief Financial Officer of NervGen.

Tags: NGEN Viatris Investor Conferences Healthcare NervGen Nasdaq stock listing biopharma
Last updated: Jan 8, 2026